Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia

Ian M. Bouligny, Graeme Murray, Thuy Ho, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A. Wages, Steven Grant, Keri R. Maher

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number107370
JournalLeukemia Research
Volume134
DOIs
StatePublished - Nov 2023
Externally publishedYes

Keywords

  • AML
  • Hypomethylating agent
  • IDH1
  • IDH2
  • Toxicity
  • Venetoclax

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this